Item Type | Name |
Concept
|
Burkitt Lymphoma
|
Concept
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Lymphoma, B-Cell
|
Concept
|
Leukemia-Lymphoma, Adult T-Cell
|
Concept
|
Lymphoma, T-Cell
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Lymphoma, B-Cell, Marginal Zone
|
Concept
|
Lymphoma, Non-Hodgkin
|
Concept
|
Lymphoma, T-Cell, Peripheral
|
Academic Article
|
Detection of BCR-ABL transcripts in acute lymphoblastic leukemia in Indian patients.
|
Academic Article
|
Expression of genes implicated in multidrug resistance in acute lymphoblastic leukemia in India.
|
Academic Article
|
Significance of MDR1, MRP1, GSTpi and GSTmu mRNA expression in acute lymphoblastic leukemia in Indian patients.
|
Academic Article
|
Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement.
|
Academic Article
|
WT1 expression in myelodysplastic syndrome.
|
Academic Article
|
CD36 - a marker for drug sensitive acute megakaryoblastic leukemia.
|
Academic Article
|
What to do when you suspect gastrointestinal lymphoma: a pathologist's perspective.
|
Academic Article
|
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
|
Academic Article
|
Intracranial mucosa-associated lymphoid tissue (MALT) lymphoma.
|
Academic Article
|
Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia.
|
Academic Article
|
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.
|
Academic Article
|
Pattern of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements in childhood acute lymphoblastic leukemia in India.
|
Academic Article
|
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.
|
Academic Article
|
Diffuse large B-cell lymphoma--more than a diffuse collection of large B cells: an entity in search of a meaningful classification.
|
Academic Article
|
MDR1 mRNA expression in young patients with acute lymphoblastic leukaemia.
|
Academic Article
|
MDR1/P-glycoprotein in haematological neoplasms.
|
Academic Article
|
A prospective study on the incidence of hepatitis B & C infections amongst patients with lymphoproliferative disorders.
|
Academic Article
|
RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.
|
Academic Article
|
Stem cell factor expression in B cell malignancies is influenced by the niche.
|
Academic Article
|
A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies.
|
Academic Article
|
PLZF staining identifies peripheral T-cell lymphomas derived from innate-like T-cells with TRAV1-2-TRAJ33 TCR-a rearrangement.
|
Academic Article
|
Cloaked in a starry sky.
|
Academic Article
|
Chromosome instability underlies hematopoietic stem cell dysfunction and lymphoid neoplasia associated with impaired Fbw7-mediated cyclin E regulation.
|
Academic Article
|
Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.
|
Academic Article
|
Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL).
|
Academic Article
|
The web of microRNA in B lymphoblastic leukemia.
|
Academic Article
|
Lymphoblastic leukemia following MDS or MDS/MPN: clinical evidence for stem cell origins of these disorders.
|
Academic Article
|
MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia.
|
Academic Article
|
B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas.
|
Academic Article
|
Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
|
Academic Article
|
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults.
|
Academic Article
|
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
|